Technology
Lung conditions in England (INHALE): March 2023 update. (
Gov.uk, 2023) https://
www.gov.uk/government/statistics/ interactive-health-atlas-of-lung-conditions- in-england-inhale-march-2023-update/ interactive-health-atlas-of-lung-conditions-in- england-inhale-march-2023-update
5 NHS England. Respiratory disease. (NHS England, 2024)
www.england.nhs.uk/ourwork/ clinical-policy/respiratory-disease/
6 NHS England. Digital service to manage high-risk chronic obstructive pulmonary disease (COPD) patients. (NHS England, 2024)
https://transform.england.nhs.uk/ key-tools-and-info/digital-playbooks/ respiratory-digital-playbook/digital-service- to-manage-high-risk-chronic-obstructive- pulmonary-disease-copd-patients/
7 Darzi A. Independent Investigation of the National Health Service in England. (
Gov.uk, 2024)
https://assets.publishing.service.gov.uk/ media/66f42ae630536cb92748271f/Lord-Darzi- Independent-Investigation-of-the-National- Health-Service-in-England-Updated-25- September.pdf
8 Locke ER, Young JP, Battaglia C, et al. Care- seeking and delay of care during COPD. NPJ Prim Care Respir Med. 2022 Feb 15;32(1):7. doi:10.1038/s41533-022-00269-9
9 National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. (NICE, 2019)
https://www.nice.
org.uk/guidance/ng115/chapter/Context
10 Larsson K, Janson C, Ställberg B, et al. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study. Int J Chron Obstruct Pulmon Dis. 2019 May 13;14:995-1008. doi:10.2147/COPD.S195382
11 NHS England. Respiratory high impact interventions. (NHS England, 2024)
www.england.nhs.uk/ourwork/prevention/ secondary-prevention/respiratory-high- impact-interventions/
12 Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-1138. doi:10.1056/ NEJMoa0909883
13 Soler-Cataluña JJ, Martínez-García MA, Román
Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary
disease.Thorax. 2005;60(11):925-931. doi:10.1136/ thx.2005.040527
14 Al Rajeh A, Steiner MC, Aldabayan Y, et al. Use, utility and methods of telehealth for patients with COPD in England and Wales: a healthcare provider
survey.BMJ Open Respir Res. 2019 Feb 18;6(1):e000345. doi:10.1136/ bmjresp-2018-000345
15 Janjua S, Carter D, Threapleton CJ, Prigmore S, Disler RT. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi:10.1002/
14651858.CD013196. pub2
16 Chan AHY, Pleasants RA, Dhand R, et al. Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective.Pulm Ther. 2021;7(2):345-376. doi:10.1007/s41030-021-00167-4
17 Al Rajeh AM, Hurst JR. Monitoring of Physiological Parameters to Predict Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review. J Clin Med. 2016 Nov 25; 5(12):108. doi:10.3390/jcm5120108
18 Caring, N. NHS tech funding falls to less than
Providing effective care for respiratory diseases, such as COPD, is a challenge for the NHS and one that is set to grow in response to the ageing population and increasing prevalence of chronic diseases
£1bn. (HSJ, 2023)
www.hsj.co.uk/technology- and-innovation/nhs-tech-funding-falls-to-less- than-1bn/
7034194.article
19 Mistry, P. With a return to basics, is the spring Budget a game changer for NHS technology? (The Kings Fund, 2024)
www.kingsfund.org.uk/insight-and-analysis/ blogs/spring-budget-game-changer-nhs- technology
20 NHS England. Inclusive digital healthcare: a framework for NHS action on digital inclusion. (NHS England, 2024)
www.england.nhs.uk/long-read/inclusive- digital-healthcare-a-framework-for-nhs- action-on-digital-inclusion/
About the author
Bipin Patel, PhD is the CEO and Founder of electronRx, a deep-tech startup developing novel chronic disease and hospital patient management solutions. He is a key digital health thought-leader with over 20 years’ experience in medical engineering, drug development and commercialisation and holds a PhD in Medical Engineering from UCL, UK.
September 2025 I
www.clinicalservicesjournal.com 43
urbans78 -
stock.adobe.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80
